The WFH 2018 World Congress will feature speakers who will discuss important—and cutting edge—topics facing the bleeding disorders community today. In the lead-up to Congress, Hemophilia World Online will be profiling several prominent speakers who will be presenting this May. Today, we look at Kathelijn Fischer, MD.
Name: Kathelijn Fischer, MD, PhD
Country: the Netherlands
Talk: How to measure outcome in hemophilia: Perspectives from patient, physician and payer
Summary: An overview of the state of the art outcome tools used in hemophilia, along with insights from the field of rheumatoid arthritis, which has already identified a “core set” of outcome tools.
Kathelijn Fischer, MD, PhD, is from Utrecht, the Netherlands, and has been involved in the hemophilia community since 1994. She works at the University Medical Center Utrecht as a Pediatric Hematologist and a Clinical Epidemiologist. Fischer is a principal investigator in several international studies on the long-term results of hemophilia treatment, and is the epidemiologist for the European Haemophilia Safety Surveillance Study (EUHASS), and the European PedNet registry. Fischer has published a number of papers on the long-term outcomes of different prophylactic regimens in hemophilia. She has also been involved in developing patient-reported outcomes (PROs) tools such as PedHal.
To find out more about other speakers who will be at the WFH 2018 World Congress, please visit the Congress program page.